BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30886958)

  • 1. High prevalence of protein tyrosine phosphatase non-receptor N22 gene functional variant R620W in systemic lupus erythematosus patients from Kuwait: implications for disease susceptibility.
    Al-Awadhi AM; Haider MZ; Sukumaran J; Balakrishnan S
    BMC Rheumatol; 2018; 2():7. PubMed ID: 30886958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
    Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
    Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity.
    Hamza RT; Awwad KS; Temsah KA; Hamed AI
    Int J Adolesc Med Health; 2013; 25(2):143-9. PubMed ID: 23314521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland.
    Piotrowski P; Lianeri M; Wudarski M; Lacki JK; Jagodziński PP
    Clin Exp Rheumatol; 2008; 26(6):1099-102. PubMed ID: 19210878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.
    Wu H; Cantor RM; Graham DS; Lingren CM; Farwell L; Jager PL; Bottini N; Grossman JM; Wallace DJ; Hahn BH; Julkunen H; Hebert LA; Rovin BH; Birmingham DJ; Rioux JD; Yu CY; Kere J; Vyse TJ; Tsao BP
    Arthritis Rheum; 2005 Aug; 52(8):2396-402. PubMed ID: 16052563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
    López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
    Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor II and PTPN22 genes polymorphisms and the risk of systemic lupus erythematosus in Egyptian children.
    Eid R; Hammad A; Abdelsalam M; Fathy AA; Abd-El Ghafaar DM; Elmarghany EB; El-Hanafy AA; Mostafa N; Niazey NA; Korkor MS; Hamdy N
    Lupus; 2021 Aug; 30(9):1449-1458. PubMed ID: 34080911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
    Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
    Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus.
    Aksoy R; Duman T; Keskin O; Düzgün N
    Mol Biol Rep; 2011 Nov; 38(8):5393-6. PubMed ID: 21384170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
    van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
    Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus.
    Kaufman KM; Kelly JA; Herring BJ; Adler AJ; Glenn SB; Namjou B; Frank SG; Dawson SL; Bruner GR; James JA; Harley JB
    Arthritis Rheum; 2006 Aug; 54(8):2533-40. PubMed ID: 16868974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
    Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
    Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility.
    Pradhan V; Borse V; Ghosh K
    J Postgrad Med; 2010; 56(3):239-42. PubMed ID: 20739780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
    Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
    Balada E; Villarreal-Tolchinsky J; Ordi-Ros J; Labrador M; Serrano-Acedo S; Martinez-Lostao L; Vilardell-Tarrés M
    Tissue Antigens; 2006 Nov; 68(5):432-8. PubMed ID: 17092257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.
    Reddy MV; Johansson M; Sturfelt G; Jönsen A; Gunnarsson I; Svenungsson E; Rantapää-Dahlqvist S; Alarcón-Riquelme ME
    Genes Immun; 2005 Dec; 6(8):658-62. PubMed ID: 16052172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.
    Kyogoku C; Langefeld CD; Ortmann WA; Lee A; Selby S; Carlton VE; Chang M; Ramos P; Baechler EC; Batliwalla FM; Novitzke J; Williams AH; Gillett C; Rodine P; Graham RR; Ardlie KG; Gaffney PM; Moser KL; Petri M; Begovich AB; Gregersen PK; Behrens TW
    Am J Hum Genet; 2004 Sep; 75(3):504-7. PubMed ID: 15273934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.
    Wipff J; Allanore Y; Kahan A; Meyer O; Mouthon L; Guillevin L; Pierlot C; Glikmans E; Bardin T; Boileau C; Cornélis F; Dieudé P
    Ann Rheum Dis; 2006 Sep; 65(9):1230-2. PubMed ID: 16464986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease.
    Zaid Y; Senhaji N; Bakhtaoui FZ; Serrano A; Serbati N; Karkouri M; Badre W; Oudghiri M; Martin J; Nadifi S
    BMC Res Notes; 2018 Nov; 11(1):783. PubMed ID: 30384859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.